Gram Research analysis shows that scientists have created detailed 3D maps of a bacterial enzyme that helps germs survive and is targeted by sulfonamide antibiotics. The high-resolution crystal structures at 1.65-1.9 Ångströms resolution reveal how the enzyme changes shape when binding to its substrate molecules, providing crucial insights for designing new antibiotics to overcome drug-resistant bacteria. These findings could eventually lead to more effective treatments for infections that current antibiotics can no longer control.
Scientists have created detailed 3D maps of a bacterial enzyme that helps germs survive and grow. This enzyme is also the target of sulfonamide antibiotics, which are becoming less effective as bacteria develop resistance. By studying the exact structure of this enzyme from heat-loving bacteria, researchers hope to design better antibiotics that can outsmart resistant germs. This discovery could lead to new treatments for infections that current drugs can no longer control, potentially saving lives by giving doctors more powerful tools against dangerous bacteria.
Key Statistics
A 2026 structural biology study published in the European Biophysics Journal achieved high-resolution crystal structures of dihydropteroate synthase at 1.65-1.9 Ångströms resolution, revealing atomic-level details of how the enzyme binds substrate molecules.
Researchers identified conserved catalytic features across bacterial species while discovering variable loop conformations and phosphate-binding residues that may explain differential sulfonamide sensitivity between bacteria like E. coli and Mycobacterium tuberculosis.
The dihydropteroate synthase enzyme naturally forms biologically relevant dimers stabilized by C-terminal α-helices, with substrate-induced ordering of flexible loops that define both the pterin- and pABA-binding pockets.
The Quick Take
- What they studied: How a specific bacterial enzyme works by examining its detailed 3D structure, especially how it binds to the molecules it needs to function
- Who participated: This was a laboratory structural biology study using bacterial samples from Thermus thermophilus HB8, not human participants
- Key finding: Researchers created high-resolution 3D maps of the enzyme in three different states, revealing how it changes shape when it grabs onto its target molecules
- What it means for you: This research could eventually lead to better antibiotics for infections resistant to current drugs, though new treatments will take years to develop and test
The Research Details
Scientists used a technique called X-ray crystallography to create detailed 3D pictures of a bacterial enzyme called dihydropteroate synthase (DHPS). Think of it like taking an extremely detailed photograph of a tiny machine from multiple angles. They examined the enzyme in three conditions: empty (apo form), with one ingredient attached (pABA), and with another ingredient attached (a pterin substitute). This allowed them to see exactly how the enzyme changes shape when it grabs onto the molecules it needs to do its job.
The researchers used bacteria that naturally live in hot springs because these bacteria’s proteins are more stable and easier to study than those from regular bacteria. They compared their findings with similar enzymes from common bacteria like E. coli and dangerous bacteria like those that cause tuberculosis, looking for patterns that might explain why some bacteria resist antibiotics.
Understanding exactly how this enzyme works at the atomic level is crucial because it’s the target of sulfonamide antibiotics—drugs that have been used for decades but are becoming less effective. By seeing the precise structure, scientists can design new drugs that fit into the enzyme’s active site better, potentially overcoming resistance mechanisms that bacteria have developed.
This is a high-quality structural biology study published in a peer-reviewed journal. The researchers achieved very high-resolution crystal structures (1.65-1.9 Ångströms), which means the atomic details are extremely clear and reliable. The study includes multiple structural states and comparisons with related enzymes from different bacteria, strengthening the findings. However, this is basic research on bacterial enzymes in test tubes, not clinical trials, so practical applications are still years away.
What the Results Show
The researchers successfully created three detailed 3D maps of the DHPS enzyme at near-atomic resolution. The enzyme has a barrel-shaped structure (called a TIM-barrel fold) and naturally forms pairs of two enzymes working together. When the enzyme binds to its target molecules, flexible loop regions of the protein reorganize themselves, creating precise pockets where the substrate molecules fit perfectly—like a lock changing shape to accommodate a specific key.
The structures revealed that the enzyme has distinct binding sites for two different molecules: one pocket for pABA (a small building block) and another for the pterin substrate (a larger, more complex molecule). The way these molecules fit into the enzyme explains how the enzyme brings them together to create the next molecule in the folate-making pathway.
Comparison with similar enzymes from other bacteria showed that while the core catalytic mechanism is conserved across species, there are important differences in how flexible loops are arranged and how phosphate groups are bound. These differences may explain why some bacteria are more resistant to sulfonamide antibiotics than others.
The study identified specific amino acid residues (the building blocks of proteins) that are critical for substrate recognition and catalysis. The research also revealed that the C-terminal regions of the enzyme (the tail ends) are essential for holding the enzyme dimer together. These structural details provide multiple potential targets for designing new inhibitor molecules that could block the enzyme’s function.
This research builds on decades of antibiotic development by providing unprecedented atomic-level detail about how DHPS works. Previous studies showed that sulfonamides block this enzyme, but this work explains exactly how and why, and reveals structural features that differ between bacterial species. This information fills important gaps that will help researchers design next-generation antibiotics that can overcome existing resistance mechanisms.
This study examined the enzyme in isolation in test tubes, not in living bacteria or organisms. The findings are based on one bacterial species (though comparisons with others are included), so results may not apply equally to all bacteria. The research doesn’t test whether new drugs based on these structures would actually work in real infections. Additionally, the study doesn’t examine how bacteria might develop new resistance mechanisms against drugs designed using this information.
The Bottom Line
This research should encourage continued investment in antibiotic development targeting DHPS, particularly for resistant bacteria. However, these findings are foundational research—new drugs based on this work will require years of additional testing before they reach patients. Current sulfonamide antibiotics remain effective for many infections, but this research supports the urgent need for alternatives as resistance increases.
This research matters most to pharmaceutical companies developing new antibiotics, infectious disease doctors treating resistant infections, and public health officials concerned about antibiotic resistance. Patients with infections resistant to current antibiotics may eventually benefit from drugs developed using this information. The general public should care because antibiotic resistance is a growing threat to modern medicine.
This is basic research, so practical applications are likely 5-10+ years away. Drug development requires additional structural studies, computer modeling, laboratory testing, animal studies, and human clinical trials before any new antibiotic reaches patients.
Frequently Asked Questions
How does understanding enzyme structure help create better antibiotics?
Detailed 3D maps of bacterial enzymes show scientists exactly where and how antibiotics can bind to block the enzyme’s function. This allows them to design drugs that fit more precisely into the enzyme’s active site, potentially overcoming resistance mechanisms bacteria have developed against older antibiotics.
Why is dihydropteroate synthase a good target for new antibiotics?
This enzyme is essential for bacteria to make folate, which they need to survive and reproduce. Humans don’t use this enzyme, so drugs targeting it can kill bacteria without directly harming human cells, making it a selective target for antimicrobial therapy.
When will new antibiotics based on this research be available?
This is foundational research, so practical applications are likely 5-10+ years away. New drugs require additional testing, computer modeling, laboratory validation, animal studies, and human clinical trials before reaching patients.
How does antibiotic resistance develop against sulfonamides?
Bacteria develop resistance through genetic changes that alter the enzyme’s structure, preventing sulfonamides from binding effectively. This research reveals structural differences between bacterial species that may explain why some bacteria are naturally more resistant than others.
Does this research apply to all bacteria or just some?
The study focused on one bacterial species but compared findings with enzymes from E. coli and Mycobacterium tuberculosis. While core catalytic features are conserved, structural variations between bacterial species suggest findings may apply differently across different bacteria.
Want to Apply This Research?
- Track antibiotic use and resistance patterns: Log each antibiotic prescription, the infection type, and treatment effectiveness to help identify personal resistance patterns and inform future healthcare decisions
- Set reminders to complete full antibiotic courses as prescribed, even when feeling better, to prevent resistance development in your personal bacterial populations
- Monitor infection recurrence rates and antibiotic effectiveness over time; share this data with healthcare providers to help them make informed decisions about which antibiotics to prescribe
This research describes basic laboratory findings about bacterial enzyme structure and is not clinical medical advice. The findings are foundational research that may eventually contribute to new antibiotic development, but no new treatments have been tested in humans. Current antibiotic treatments should be used as prescribed by healthcare providers. Anyone with concerns about antibiotic-resistant infections should consult with a qualified healthcare professional. This article is for educational purposes and should not replace professional medical guidance.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.